TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
PTGX

Protagonist Therapeutics Inc

Healthcare · Biotechnology

138.70$ -1.4% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Protagonist Therapeutics Inc (PTGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 886 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PTGX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
330 358 629 615 604 745 742 718 702 670 697 886
325 356 628 571 477 592 606 603 586 578 613 807
231 187 173 356 131 97 140 169 114 128 194 420
321 342 323 564 469 419 574 570 576 567 548 783
0.1 10 300 1.4 2.7 168 27 28 0.6 4.5 57 13
-2.1 – – 0.0 – – – – – – – –
28 21 69 73 72 69 53 50 56 55 42 44
28 21 40 42 45 47 35 36 45 45 35 37
1.8 1.1 0.5 2.7 0.0 0.5 1.6 2.2 2.2 2.3 2.3 2.4
1.3 0.8 3.5 3.6 3.0 1.6 2.9 3.2 5.6 5.3 8.4 3.5
302 337 560 541 532 675 689 668 645 615 655 842
-643 -616 -408 -439 -472 -341 -352 -387 -426 -471 -467 -304
59 62 64 61 62 66 63 64 64 64 70 71

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?